LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Stock List・Alcon Inc

Alcon Inc

Closed

SectorHealthcare

66.57 3.5

Buy Sell

Overview

Share price change

24h

Current

Min

64.21

Max

66.58

Key metrics
By Trading Economics
Income	-32M 185M
Sales	-65M 2.7B
P/E Sector Avg	39.341 49.888
EPS	0.85
Dividend yield	0.55
Profit margin	6.984
Employees	25,000
EBITDA	168M 689M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+34.72% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	0.55% 2.38%
Next Earnings	10 Aug 2026

Market Stats
By TradingEconomics
Market Cap	-4.7B 32B
Previous open	63.07
Previous close	66.57

News Sentiment

By Acuity

26%

74%

59 / 344 Healthcare

Alcon Inc Chart

Past performance is not a reliable indicator of future results.

Related News

17 Mar 2026, 14:42 UTC

Major Market Movers

Acquisitions, Mergers, Takeovers

Lensar Share Slide on Terminated Merger Deal With Alcon

16 Mar 2026, 21:37 UTC

Acquisitions, Mergers, Takeovers

Lensar and Alcon Agree to Terminate Merger

6 Jan 2026, 15:11 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9 Dec 2025, 18:51 UTC

Acquisitions, Mergers, Takeovers

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 Dec 2025, 15:54 UTC

Major Market Movers

Acquisitions, Mergers, Takeovers

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 Dec 2025, 14:32 UTC

Acquisitions, Mergers, Takeovers

Alcon Upgrades Offer Price for Staar Surgical

5 May 2026, 21:25 UTC

Earnings

Alcon Inc. 1Q EPS 39c >ALC.EB

5 May 2026, 21:25 UTC

Earnings

Alcon Inc. 1Q Rev $2.71B >ALC.EB

16 Mar 2026, 20:59 UTC

Acquisitions, Mergers, Takeovers

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 Mar 2026, 20:59 UTC

Acquisitions, Mergers, Takeovers

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 Mar 2026, 20:59 UTC

Acquisitions, Mergers, Takeovers

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 Mar 2026, 20:57 UTC

Acquisitions, Mergers, Takeovers

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

25 Feb 2026, 22:29 UTC

Acquisitions, Mergers, Takeovers

Lensar Expects to Close Transaction in 1H of 2026 >LNSR

25 Feb 2026, 22:29 UTC

Acquisitions, Mergers, Takeovers

Lensar, Alcon Continue to Cooperate With FTC in Connection With Request for Additional Info >LNSR

25 Feb 2026, 22:28 UTC

Acquisitions, Mergers, Takeovers

LENSAR Provides Update on Pending Acquisition by Alcon

24 Feb 2026, 21:41 UTC

Earnings

Alcon 4Q Rev $2.72B >ALC.EB

7 Jan 2026, 01:00 UTC

Acquisitions, Mergers, Takeovers

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6 Jan 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 Jan 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 Jan 2026, 15:21 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6 Jan 2026, 14:56 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6 Jan 2026, 14:14 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6 Jan 2026, 14:14 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6 Jan 2026, 14:14 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6 Jan 2026, 14:13 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9 Dec 2025, 14:17 UTC

Acquisitions, Mergers, Takeovers

Alcon Ups Offer Price for Staar Surgical

9 Dec 2025, 13:34 UTC

Acquisitions, Mergers, Takeovers

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 Dec 2025, 13:33 UTC

Acquisitions, Mergers, Takeovers

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 Dec 2025, 13:33 UTC

Acquisitions, Mergers, Takeovers

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 Dec 2025, 13:33 UTC

Acquisitions, Mergers, Takeovers

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

Peer Comparison

Price change

Alcon Inc Forecast

Price Target

By TipRanks

34.72% upside

12 Months Forecast

Average 86.52 USD 34.72%

High 108.762 USD

Low 63.234 USD

Based on 12 Wall Street analysts offering 12 month price targets forAlcon Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to Alcon Inc - Dist in the past 3 months.

Sentiment

By Acuity

59 / 344 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.